ConductScience.org, home

Paper2140808

Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma.

Otsuji E and 4 others. Gastroenterol Jpn, 1990. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma. Papers, record 2140808. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2140808

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma.
PubMed
Journal
Gastroenterol Jpn
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.73
iCite
Revised in PubMed
2026-10-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Otsuji EE
2Takahashi TT
3Yamaguchi TT
4Yamaguchi NN
5Imanishi JJ

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibiotics, AntineoplasticMajor topic
Antibodies, MonoclonalMajor topic
Pancreatic NeoplasmsMajor topic
ZinostatinMajor topic
Cell Survival
Drug Screening Assays, Antitumor
Humans
Immunoenzyme Techniques
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1726500Cancer of the pancreas, international mortality trends.World Health Stat Q1978https://conductscience.org/library/papers/726500PubMed
24271094[Neocarzinostatin. A new chemotherapeutic approach to acute leukemia (author's transl)].Nouv Rev Fr Hematol1973https://conductscience.org/library/papers/4271094PubMed
3143343In vitro inhibition of human leukemic cells (CCRF-CEM) by agarose-immobilized neocarzinostatin.Cancer Res1977https://conductscience.org/library/papers/143343PubMed
42962733Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma.Cancer1988https://conductscience.org/library/papers/2962733PubMed
56458289Biological activity of the antitumor protein neocarzinostatin coupled to a monoclonal antibody by N-succinimidyl 3-(2-pyridyldithio)-propionate.Biochem Biophys Res Commun1981https://conductscience.org/library/papers/6458289PubMed
639562Neocarzinostatin: spectral characterization and separation of a non-protein chromophore.Biochem Biophys Res Commun1979https://conductscience.org/library/papers/39562PubMed
76445749Effect of nonprotein chromophore removal on neocarzinostatin action.Biochemistry1980https://conductscience.org/library/papers/6445749PubMed
87272905Demographic characteristics of cancer of the pancreas: mortality, incidence, and survival.Cancer1981https://conductscience.org/library/papers/7272905PubMed
97042540In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies.Immunol Rev1982https://conductscience.org/library/papers/7042540PubMed
10164280The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies.Cancer Res1975https://conductscience.org/library/papers/164280PubMed
111172191Continuous cultures of fused cells secreting antibody of predefined specificity.Nature1975https://conductscience.org/library/papers/1172191PubMed
12164279The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.Cancer Res1975https://conductscience.org/library/papers/164279PubMed
136211130Neocarzinostatin in cancer chemotherapy (review).Anticancer Res1981https://conductscience.org/library/papers/6211130PubMed
146166661Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.J Histochem Cytochem1981https://conductscience.org/library/papers/6166661PubMed
153530437Acid protease secreted from human pancreatic carcinoma cell line HPC-YT into serum-free, chemically defined medium.Cancer Res1986https://conductscience.org/library/papers/3530437PubMed
163526636A monoclonal antibody against human colon cancers.Tohoku J Exp Med1986https://conductscience.org/library/papers/3526636PubMed
172967049[Clinical application of monoclonal antibody-drug conjugates in colorectal carcinoma].Gan To Kagaku Ryoho1988https://conductscience.org/library/papers/2967049PubMed
183621157Stimulation of low density lipoprotein receptor activity by conditioned medium from a human cancer cell line.Cancer Res1987https://conductscience.org/library/papers/3621157PubMed
196444585Chemotherapy for bladder cancer with neocarzinostatin: evaluation of systemic administration.Eur J Cancer (1965)1980https://conductscience.org/library/papers/6444585PubMed
206447549Fluorophotometric enzyme immunoassay of neocarzinostatin using peroxidase as a label.Chem Pharm Bull (Tokyo)1980https://conductscience.org/library/papers/6447549PubMed

See all 21 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
8761376Distribution of neocarzinostatin conjugated to biotinylated chimeric monoclonal antibody Fab fragments after administration of avidin.Br J Cancer1996https://conductscience.org/library/papers/8761376PubMed
8630275Effects of neocarzinostatin-chimeric Fab conjugates on the growth of human pancreatic carcinoma xenografts.Br J Cancer1996https://conductscience.org/library/papers/8630275PubMed
8407556Enhanced tumor localization of radiolabeled Fab fragments of monoclonal antibody A7 in nude mice bearing human pancreatic carcinoma xenografts.Jpn J Cancer Res1993https://conductscience.org/library/papers/8407556PubMed
8080722In vitro reactivity and in vivo biodistribution of the monoclonal antibody A7 using human gastric carcinoma cell lines.Br J Cancer1994https://conductscience.org/library/papers/8080722PubMed
8014111Biodistribution of neocarzinostatin conjugated to chimeric Fab fragments of the monoclonal antibody A7 in nude mice bearing human pancreatic cancer xenografts.Jpn J Cancer Res1994https://conductscience.org/library/papers/8014111PubMed
1387634Efficacy and specificity of a monoclonal antibody-drug conjugate in chemotherapy by intratumoral injection.Jpn J Cancer Res1992https://conductscience.org/library/papers/1387634PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2140808

GET https://conductscience.org/api/papers/v1/2140808/references?page=2